Faeth Therapeutics, Inc. ($FTH)
Filing Information
| Accession Number | 0002111813-26-000010 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 24, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
109,736
Total Value
$117,465.96
P&L
+40.5% (+$22,448.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jun 22, 2026 | Purchase | 2,806 | $19.76 | $55,446.56 | 764,234 | Direct | โ | View Details | |
Director | Common Stock | โ | Jun 22, 2026 | Exercise/Conversion | 45,252 | $1.16 | $52,492.32 | 809,486 | Direct | โ | View Details | |
Director | Common Stock | โ | Jun 22, 2026 | Exercise/Conversion | 8,213 | $1.16 | $9,527.08 | 817,699 | Direct | โ | View Details | |
Director | Employee Stock Option (right to buy) | Derivative | Jun 22, 2026 | Exercise/Conversion | 45,252 | $0.00 | $0.00 | 91,632 | Direct | โ | View Details | |
Director | Employee Stock Option (right to buy) | Derivative | Jun 22, 2026 | Exercise/Conversion | 8,213 | $0.00 | $0.00 | 4,107 | Direct | โ | View Details |